动脉瘤性蛛网膜下腔出血潜在生物标记物的研究进展
Research Progress on Potential Biomarkers of Aneurysmal Subarachnoid Hemorrhage
DOI: 10.12677/ACM.2024.142504, PDF,   
作者: 张彦兵：新疆医科大学研究生院，新疆 乌鲁木齐；吴红星*：新疆维吾尔自治区人民医院神经外科，新疆 乌鲁木齐
关键词: 动脉瘤性蛛网膜下腔出血；生物标记物；炎症反应；Aneurysmal Subarachnoid Hemorrhage； Biomarkers； Inflammatory Response
摘要: 动脉瘤性蛛网膜下腔出血是一种常见的神经系统急症，有着极高的致死率和致残率，目前对于动脉瘤性蛛网膜下腔出血的检查及预后评估主要通过影像手段如CT、CTA、MRA、DSA来实现，但是这些检查手段有着严格的适应症、禁忌症、潜在造影剂和辐射威胁，此外术后患者需进行长期随访，观察脑动脉瘤的生长及预后情况，部分患者受到医疗、经济等条件限制。因此，寻找快捷、实用、有效和经济的评估方法来检测动脉瘤性蛛网膜下腔出血的治疗效果和预后是非常有必要的。
Abstract: Aneurysmal subarachnoid hemorrhage is a common neurological emergency with extremely high mortality and disability rates. Currently, the examination and prognosis evaluation of aneurysmal subarachnoid hemorrhage are mainly achieved through imaging methods such as CT, CTA, MRA, and DSA. However, these examination methods have strict indications, contraindications, potential contrast agents, and radiation threats. In addition, postoperative patients need to undergo long-term follow-up, observing the growth and prognosis of cerebral aneurysms, some patients are limited by medical and economic conditions. Therefore, it is necessary to find a fast, practical, effective, and economical evaluation method to detect the treatment effect and prognosis of aneu-rysmal subarachnoid hemorrhage.
文章引用：张彦兵, 吴红星. 动脉瘤性蛛网膜下腔出血潜在生物标记物的研究进展[J]. 临床医学进展, 2024, 14(2): 3604-3610. https://doi.org/10.12677/ACM.2024.142504

参考文献

[1] Sharma, T., Datta, K.K., Kumar, M., et al. (2020) Intracranial Aneurysm Biomarker Candidates Identified by a Prote-ome-Wide Study. OMICS, 24, 483-492. [Google Scholar] [CrossRef] [PubMed]
[2] Batista, S., Bocanegra-Becerra, J.E., Claassen, B., et al. (2023) Biomarkers in Aneurysmal Subarachnoid Hemorrhage: A Short Review. World Neurosurgery: X, 19, Article ID: 100205. [Google Scholar] [CrossRef] [PubMed]
[3] Lawton, M.T. and Vates, G.E. (217) Subarachnoid Hemorrhage. The New England Journal of Medicine, 377, 257-266. [Google Scholar] [CrossRef] 
[4] Maruhashi, T. and Higashi, Y. (2021) An Overview of Pharma-cotherapy for Cerebral Vasospasm and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage. Expert Opinion on Pharmacotherapy, 22, 1601-1614. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, Y., Li, L., Jia, L., et al. (2021) Neutrophil Counts as Promising Marker for Predicting in-Hospital Mortality in Aneurysmal Subarachnoid Hemorrhage. Stork, 52, 3266-3275. [Google Scholar] [CrossRef] 
[6] Bodaghi, A., Fattahi, N. and Ramazani, A. (2023) Biomarkers: Promising and Valuable Tools towards Diagnosis, Prognosis and Treatment of Covid-19 and Other Diseases. Heliyon, 9, E13323. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, B., Lin, L., Yuan, F., et al. (2021) Clinical Application Values of Neutrophil-to-Lymphocyte Ratio in Intracranial Aneurysms. Aging, 13, 5250-5262. [Google Scholar] [CrossRef] [PubMed]
[8] Lucke-Wold, B.P., Logsdon, A.F., Manoranjan, B., et al. (2016) An-eurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review. International Journal of Molecular Sciences, 17, Article 497. [Google Scholar] [CrossRef] [PubMed]
[9] Okada, T. and Suzuki, H. (2017) Toll-Like Receptor 4 as a Possible Therapeutic Target for Delayed Brain Injuries after Aneurysmal Subarachnoid Hemorrhage. Neural Regeneration Re-search, 12, 193-196. [Google Scholar] [CrossRef] [PubMed]
[10] Vincent, J.L., Donadello, K. and Schmit, X. (2011) Biomarkers in the Critically Ill Patient: C-Reactive Protein. Critical Care Clinics, 27, 241-251. [Google Scholar] [CrossRef] [PubMed]
[11] Fountas, K.N., Tasiou, A., Kapsalaki, E.Z., et al. (2009) Serum and Cerebrospinal Fluid C-Reactive Protein Levels as Predictors of Vasospasm in Aneurysmal Subarachnoid Hemorrhage. Neurosurgical Focus, 26, E22. [Google Scholar] [CrossRef] 
[12] Alessandro, O., Rene, W., Stefan, W., et al. (2022) C-Reactive Protein Elevation Predicts In-Hospital Deterioration after Aneurysmal Subarachnoid Hemorrhage: A Retrospective Observational Study. Acta Neurochirurgica, 164, 1805- 1814. [Google Scholar] [CrossRef] [PubMed]
[13] Lee, S., Kim, Y.O. and Ryu, J.A. (2020) Clinical Usefulness of Early Serial Measurements of C-Reactive Protein as Outcome Predictors in Patients with Subarachnoid Hemorrhage. BMC Neurology, 20, Article No. 112. [Google Scholar] [CrossRef] [PubMed]
[14] Gouvê, A., Bogossian, E., Taleb, C., Aspide, R., et al. (2023) Cerebro-Spinal Fluid Glucose and Lactate Concentrations Changes in Response to Therapies in Patients with Primary Brain Injury: The START-TRIP Study. Critical Care, 27, Article No. 130. [Google Scholar] [CrossRef] [PubMed]
[15] Taccone, F.S., Badenes, R., Arib, S., et al. (2020) Cerebrospinal Fluid Glucose and Lactate Levels after Subarachnoid Hemorrhage: A Multicenter Retrospective Study. Journal of Neurosurgical Anesthesiology, 32, 170-176. [Google Scholar] [CrossRef] 
[16] Aisiku, I.P., Chen, P.R., Truong, H., et al. (2016) Admis-sion Serum Lactate Predicts Mortality in Aneurysmal Subarachnoid Hemorrhage. The American Journal of Emergency Medicine, 34, 708-712. [Google Scholar] [CrossRef] [PubMed]
[17] Liu, X., Shen, Y., Wang, H., et al. (2016) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study. Mediators of In-flammation, 2016, Article ID: 8191254. [Google Scholar] [CrossRef] [PubMed]
[18] Giede-Jeppe, A., Reichl, J., Sprügel, M.I., et al. (2019) Neutro-phil-to-Lymphocyte Ratio as an Independent Predictor for Unfavorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage. Journal of Neurosurgery, 132, 400- 407. [Google Scholar] [CrossRef] 
[19] Shi, M., Yang, C., Tang, Q.W., et al. (2021) The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Observational Studies. Frontiers in Neurology, 12, Article 745560. [Google Scholar] [CrossRef] [PubMed]
[20] Lucke-Wold, B., Hosaka, K., Dodd, W., et al. (2021) Interleukin-6: Important Mediator of Vasospasm Following Subarachnoid Hemorrhage. Current Neurovascular Research, 18, 364-369. [Google Scholar] [CrossRef] [PubMed]
[21] Kao, H.W., Lee, K.W., Kuo, C.L., et al. (2015) In-terleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms. PLOS ONE, 10, e132115. [Google Scholar] [CrossRef] [PubMed]
[22] Chaudhry, S.R., Stoffel-Wagner, B., Kinfe, T.M., et al. (2017) Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications. International Journal of Molecular Sciences, 18, Article 2580. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, W.X., Springer, J.E. and Hatton, K.W. (2021) MicroRNAs as Biomarkers for Predicting Complications Following Aneurysmal Subarachnoid Hemorrhage. International Journal of Molecular Sciences, 22, Article 9492. [Google Scholar] [CrossRef] [PubMed]
[24] Müller, A.H., Povlsen, G.K., Bang-Berthelsen, C.H., et al. (2015) Regulation of MicroRNAs MiR-30a and MiR-143 in Cerebral Vasculature after Experimental Subarachnoid Hemorrhage in Rats. BMC Genomics, 16, Article No. 119. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, D., Han, L., Wu, X., et al. (2014) Genome-Wide MicroRNA Changes in Human Intracranial Aneurysms. BMC Neurology, 14, Article No. 188. [Google Scholar] [CrossRef] [PubMed]
[26] Supriya, M., Christopher, R., Indira Devi, B., et al. (2020) Cir-culating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture. Molecular Diagnosis & Therapy, 24, 351-364. [Google Scholar] [CrossRef] [PubMed]
[27] Lai, N.S., Zhang, J.Q., Qin, F.Y., et al. (2017) Serum MicroRNAs Are Non-Invasive Biomarkers for the Presence and Progression of Subarachnoid Haemorrhage. Bioscience Reports, 37, BSR20160480. [Google Scholar] [CrossRef] 
[28] Hong, C.M., Tosun, C., Kurland, D.B., et al. (2014) Biomarkers as Outcome Predictors in Subarachnoid Hemorrhage—A Systematic Review. Biomarkers, 19, 95-108. [Google Scholar] [CrossRef] 
[29] Abboud, T., Mende, K.C., Jung, R., et al. (2017) Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. World Neurosurgery, 108, 669-675. [Google Scholar] [CrossRef] [PubMed]
[30] Balanca, B., Ritzenthaler, T., Gobert, F., et al. (2020) Significance and Diagnostic Accuracy of Early S100B Serum Concentration after Aneurysmal Subarachnoid Hemorrhage. Journal of Clinical Medicine, 9, Article 1746. [Google Scholar] [CrossRef] [PubMed]
[31] Zhou, Z., Zeng, J., Yu, S., et al. (2022) Neurofilament Light Chain and S100B Serum Levels Are Associated with Disease Severity and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage. Frontiers in Neurology, 13, Article 956043. [Google Scholar] [CrossRef] [PubMed]
[32] Troutwine, B.R., Hamid, L., Lysaker, C.R., et al. (2022) Apolipoprotein E and Alzheimer’s Disease. Acta Pharmaceutica Sinica B, 12, 496-510. [Google Scholar] [CrossRef] [PubMed]
[33] Suvatha, A., Kandi, S.M., Bhat, D.I., et al. (2017) Apolipoprotein E Polymorphism and the Risk of Aneurysmal Subarachnoid Hemorrhage in a South Indian Population. Cellular & Molecular Biology Letters, 22, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[34] Nakatsuka, Y., Shiba, M., Nishikawa, H., et al. (2018) Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome after Aneurysmal Subarachnoid Hemorrhage. Molecular Neurobiology, 55, 6841-6849. [Google Scholar] [CrossRef] [PubMed]
[35] Abate, M.G., Moretto, L., Licari, I., et al. (2019) Osteopontin in the Cerebrospinal Fluid of Patients with Severe Aneurysmal Subarachnoid Hemorrhage. Cells, 8, Article 695. [Google Scholar] [CrossRef] [PubMed]

为你推荐